Pranay Soni1,2, Mark A Davison1, Jianning Shao3, Arbaz Momin3, Diana Lopez3, Lilyana Angelov1,2,3, Gene H Barnett1,2,3, Joung H Lee4, Alireza M Mohammadi1,2,3, Varun R Kshettry1,2,3, Pablo F Recinos5,6,7. 1. Department of Neurological Surgery, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave., CA-51, Cleveland, OH, 44195, USA. 2. Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA. 3. Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. 4. Department of Neurological Surgery, Hollywood Presbyterian Medical Center, Los Angeles, CA, USA. 5. Department of Neurological Surgery, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave., CA-51, Cleveland, OH, 44195, USA. recinop@ccf.org. 6. Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA. recinop@ccf.org. 7. Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. recinop@ccf.org.
Abstract
PURPOSE: WHO grade II meningiomas behave aggressively, with recurrence rates as high as 60%. Although complete resection in low-grade meningiomas is associated with a relatively low recurrence rate, the impact of complete resection for WHO grade II meningiomas is less clear. We studied the association of extent of resection with overall and progression-free survivals in patients with WHO grade II meningiomas. METHODS: A retrospective database review was performed to identify all patients who underwent surgical resection for intracranial WHO grade II meningiomas at our institution between 1995 and 2019. Kaplan-Meier analysis was used to compare overall and progression-free survivals between patients who underwent gross total resection (GTR) and those who underwent subtotal resection (STR). Multivariable Cox proportional-hazards analysis was used to identify independent predictors of tumor recurrence and mortality. RESULTS: Of 214 patients who underwent surgical resection for WHO grade II meningiomas (median follow-up 53.4 months), 158 had GTR and 56 had STR. In Kaplan-Meier analysis, patients who underwent GTR had significantly longer progression-free (p = 0.002) and overall (p = 0.006) survivals than those who underwent STR. In multivariable Cox proportional-hazards analysis, GTR independently predicted prolonged progression-free (HR 0.57, p = 0.038) and overall (HR 0.44, p = 0.017) survivals when controlling for age, tumor location, and adjuvant radiation. CONCLUSIONS: Extent of resection independently predicts progression-free and overall survivals in patients with WHO grade II meningiomas. In an era of increasing support for adjuvant treatment modalities in the management of meningiomas, our data support maximal safe resection as the primary goal in treatment of these patients.
PURPOSE: WHO grade II meningiomas behave aggressively, with recurrence rates as high as 60%. Although complete resection in low-grade meningiomas is associated with a relatively low recurrence rate, the impact of complete resection for WHO grade II meningiomas is less clear. We studied the association of extent of resection with overall and progression-free survivals in patients with WHO grade II meningiomas. METHODS: A retrospective database review was performed to identify all patients who underwent surgical resection for intracranial WHO grade II meningiomas at our institution between 1995 and 2019. Kaplan-Meier analysis was used to compare overall and progression-free survivals between patients who underwent gross total resection (GTR) and those who underwent subtotal resection (STR). Multivariable Cox proportional-hazards analysis was used to identify independent predictors of tumor recurrence and mortality. RESULTS: Of 214 patients who underwent surgical resection for WHO grade II meningiomas (median follow-up 53.4 months), 158 had GTR and 56 had STR. In Kaplan-Meier analysis, patients who underwent GTR had significantly longer progression-free (p = 0.002) and overall (p = 0.006) survivals than those who underwent STR. In multivariable Cox proportional-hazards analysis, GTR independently predicted prolonged progression-free (HR 0.57, p = 0.038) and overall (HR 0.44, p = 0.017) survivals when controlling for age, tumor location, and adjuvant radiation. CONCLUSIONS: Extent of resection independently predicts progression-free and overall survivals in patients with WHO grade II meningiomas. In an era of increasing support for adjuvant treatment modalities in the management of meningiomas, our data support maximal safe resection as the primary goal in treatment of these patients.
Entities:
Keywords:
Atypical meningioma; Extent of resection; Overall survival; Progression-free survival; Simpson grade; WHO grade II meningioma
Authors: Varun R Kshettry; Quinn T Ostrom; Carol Kruchko; Ossama Al-Mefty; Gene H Barnett; Jill S Barnholtz-Sloan Journal: Neuro Oncol Date: 2015-05-24 Impact factor: 12.300
Authors: Daniel R Klinger; Bruno C Flores; Jeremy J Lewis; Kimmo Hatanpaa; Kevin Choe; Bruce Mickey; Samuel Barnett Journal: World Neurosurg Date: 2015-04-25 Impact factor: 2.104
Authors: Ricardo J Komotar; J Bryan Iorgulescu; Daniel M S Raper; Eric C Holland; Kathryn Beal; Mark H Bilsky; Cameron W Brennan; Viviane Tabar; Jonathan H Sherman; Yoshiya Yamada; Philip H Gutin Journal: J Neurosurg Date: 2012-08-24 Impact factor: 5.115
Authors: Douglas A Hardesty; Andrew B Wolf; David G Brachman; Heyoung L McBride; Emad Youssef; Peter Nakaji; Randall W Porter; Kris A Smith; Robert F Spetzler; Nader Sanai Journal: J Neurosurg Date: 2013-02-08 Impact factor: 5.115
Authors: Matthias Millesi; Alice Senta Ryba; Johannes A Hainfellner; Thomas Roetzer; Anna Sophie Berghoff; Matthias Preusser; Gerwin Heller; Erwin Tomasich; Felix Sahm; Karl Roessler; Stefan Wolfsberger Journal: Front Oncol Date: 2022-03-09 Impact factor: 6.244
Authors: John Lynes; Gabriel Flores-Milan; Sebastian Rubino; John Arrington; Robert Macaulay; James K C Liu; Andre Beer-Furlan; Nam D Tran; Michael A Vogelbaum; Arnold B Etame Journal: Front Oncol Date: 2022-08-12 Impact factor: 5.738